On the afternoon of September 11, Deputy Secretary of the Party Committee and Secretary of the Disciplinary Committee of the Cancer Hospital of the Chinese Academy of Sciences (Zhejiang Cancer Hospital), Zhu Zhenwei, Chairman of the Zhejiang Cancer Foundation, Wu Rong, Chief of Infrastructure, Du Lingbin, Director of the Provincial Cancer Prevention Office, and the Party and Government Office Zhou Jingnan, deputy director and secretary of the Youth League Committee, Wang Yifeng, deputy director of the Publicity Department, Zhou Guoming, deputy director of the Physical Examination Center, Lin Yao, Department of Radiology, Chen Wenbing, Wang Youqing, Chen Yaoyao, and experts from various departments visited Fangge Pharmaceutical for research and guidance. Qingyuan County County Party Committee Member, Baishanzu Town Party Committee Secretary Chen Shuaifeng, Deputy County Mayor Wu Xiaojun, Li Peng, County Health Bureau Party Secretary and Director Huang Sijin, County People's Hospital Medical Community Party Secretary Guan Tingyong, Deputy Secretary, Dean Lin Jun Accompany.
Secretary of the Disciplinary Committee of Hu Qingyutang Group, Deputy General Manager of Hu Qingyutang Pharmaceutical Holdings Co., Ltd., Chairman Ren Haibin of Zhejiang Fangge Pharmaceutical Co., Ltd., General Manager Fan Jiandong, Director and Deputy General Manager Huang Lichun, and Deputy General Manager Liu Shizhu received expert leaders at all levels.
The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital) was founded in October 1963. It is the first professional research institution of the Chinese Academy of Sciences with oncology medicine as the main research direction. It is one of the first four cancer hospitals established in New China. Integrating tumor prevention, medical treatment, scientific research, teaching, and rehabilitation, it undertakes the important task of national tumor prevention and treatment, and plays a leading role in the nationwide cancer prevention and treatment work. It was established with the support of the Affiliated Cancer Hospital of the Chinese Academy of Sciences (Zhejiang Cancer Hospital) The Institute of Oncology and Basic Medicine of the Chinese Academy of Sciences is the first national-level life and health research institution introduced in our province. The two parties will jointly carry out cutting-edge life science research and major technological innovations, and strive to build a leading domestic and world-class public cancer research platform, Clinical practice platform and achievement transformation platform.
Visit the grid exhibition hall
In the process of visiting the corporate exhibition hall, the experts and leaders learned about the corporate culture and development of Fangge Pharmaceuticals. They said: Fangge people uphold Hu Qingyutang’s century-old ancestral motto of "No Bullying", and the truth-seeking and pragmatic persistence in "taking fungi The corporate philosophy of "Essence, Quality of Life" serves human health, which is very valuable.
In the seminar room, experts, leaders and company leaders spoke freely and fully communicated. During the conversation, they were full of praise for the health products of the edible and medicinal fungi of the pharmaceutical industry, especially the Huishuhua Jiaonang.
What is Maitake?
Maitake, also known as "maitake mushroom", is a rare medicinal edible fungus. Its active ingredients have high medicinal value and can effectively inhibit the growth of tumor cells. In the 1980s, Wu Kedian, then director of the Institute of Edible Fungi of Qingyuan County, presided over the successful research on the artificial cultivation technology of Maitake and realized the industrial development, filling the gap in artificial cultivation of Maitake in my country. Out of research on the effective ingredients of Maitake, Qingyuan County Microbial Products Factory was established, which was the predecessor of Fangge Pharmaceutical. In 2004, the research and development and marketing of the only Maitake anti-tumor drug in my country and even in the world-Maitake capsules, pioneered medicinal fungal immunotherapy for tumors.
In March this year, Huishuhua Jiaonang formally entered the National University of Science and Technology Affiliated Cancer Hospital (Provincial Cancer Hospital), bringing good news to the majority of cancer patients, and also gained the trust of the majority of cancer patients, providing more relief and treatment of diseases s help. At the same time, it provides a better platform and opportunity for the later cooperation between the two parties. The intensive and deep processing of edible and medicinal fungi is a big health industry with great potential in the 21st century. Fangge Pharmaceuticals will continue to work hard, integrate production, education and research resources, and cooperate with professional platforms to in-depth research and development of health products for edible and medicinal fungi, and make fungal polysaccharide series products Serve more consumer groups and lead the health trend.
